Evidence map›Paper›PMID 39102342›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Computed Tomography Imaging Guided Microenvironment-Responsive Ir@WO

Jiayu Song, Yue Feng, Jiazhuo Yan, Ying Wang, Weixiao Yan, Nan Yang, Tusheng Wu, Sijia Liu, Yuan Wang, Nannan Zheng and 2 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Computed Tomography Imaging Guided Microenvironment-Responsive Ir@WOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jiayu SongDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Yue FengDepartment of Gynecological Oncology, Zhejiang Cancer Hospital, Zhengzhou, Zhejiang, 310022, China.
Jiazhuo YanDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Ying WangDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Weixiao YanSchool of Medicine and Health, Key Laboratory of Microsystems and Microstructures Manufacturing, Harbin Institute of Technology, Harbin, 150001, China.
Nan YangDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Tusheng WuDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Sijia LiuDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Yuan WangDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Nannan ZhengSchool of Medicine and Health, Key Laboratory of Microsystems and Microstructures Manufacturing, Harbin Institute of Technology, Harbin, 150001, China.
Liangcan HeSchool of Medicine and Health, Key Laboratory of Microsystems and Microstructures Manufacturing, Harbin Institute of Technology, Harbin, 150001, China.ORCID 0000-0002-9415-9535
Yunyan ZhangDepartment of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, 150001, China.

Funding

China Postdoctoral Science Foundation 2022TQ0094Fundamental Research Funds for the Central UniversitiesHeilongjiang Touyan Team HITTY-20190036National Natural Science Foundation of China 82271880National Natural Science Foundation of China 82303691National Natural Science Foundation of China U20A20339Natural Science Foundation of Heilongjiang Province of China for Excellent Young Scholars YQ2022E020Shenzhen Medical Research A2302046
6 · The paper itself

Abstract

Radiotherapy (RT) is often administered, either alone or in combination with other therapies, for most malignancies. However, the degree of tumor oxygenation, damage to adjacent healthy tissues, and inaccurate guidance remain issues that result in discontinuation or failure of RT. Here, a multifunctional therapeutic platform based on Ir@WO

Indexed as

Radiation-Sensitizing AgentsTomography, X-Ray ComputedTumor MicroenvironmentTungstenAnimalsCatalysisCell Line, TumorDisease Models, AnimalHumansHydrogen PeroxideMiceNanoparticlesOxidesHydrogen PeroxideOxidesRadiation-Sensitizing AgentsTungstentungsten oxidedual catalytic activityhypoxia reliefnanoreactorsradiotherapysynergistic therapies

Identifiers

PMID39102342
PMCPMC11481196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.